The forecast for sales of Modulators of the Genital System and Sex Hormones in Germany shows a consistent value of $5.6 USD per capita from 2024 to 2028. This flat line in the forecast suggests no expected percentage growth or decline in sales per capita over this period. Compared to 2023, there seems to be no variation, indicating stability in the market demand.
Future trends to watch include:
- Potential regulatory changes affecting hormone therapies
- Emerging competition from alternative therapies
- Shifts in demographic trends or healthcare policies impacting demand
